An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.

Clinical trial NCT00474513 · COMPLETED

Trial details

NCT number: NCT00474513
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Cognitive Impairment Dementia

Start date: 2007-03-01
Primary completion: 2008-03-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.